Zolmitriptan (gZomig) is used in the acute treatment of migraine attacks. The patent expired in 2012 and has lot of competitors like Sun, Glenmark, Mylan and Teva already present in the market. Seems to be a 'me too' kind of product. It had US sales of USD 163 million pre generic.
Subscribe To Our Free Newsletter |